Exact Sciences Corporation
EXAS
$46.35
$0.461.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.76B | 2.69B | 2.61B | 2.53B | 2.50B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.76B | 2.69B | 2.61B | 2.53B | 2.50B |
| Cost of Revenue | 840.15M | 811.20M | 783.66M | 750.80M | 737.56M |
| Gross Profit | 1.92B | 1.88B | 1.83B | 1.78B | 1.76B |
| SG&A Expenses | 1.66B | 1.61B | 1.60B | 1.63B | 1.61B |
| Depreciation & Amortization | 0.00 | 2.21M | 765.00K | 383.00K | 0.00 |
| Other Operating Expenses | -- | -2.03M | -2.03M | -2.03M | -2.03M |
| Total Operating Expenses | 2.93B | 2.87B | 2.84B | 2.82B | 2.78B |
| Operating Income | -171.86M | -177.89M | -232.94M | -287.41M | -277.00M |
| Income Before Tax | -1.04B | -210.57M | -172.10M | -237.67M | -201.75M |
| Income Tax Expenses | -7.30M | 3.47M | 2.91M | 2.55M | 2.40M |
| Earnings from Continuing Operations | -1.03K | -214.04 | -175.01 | -240.23 | -204.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03B | -214.04M | -175.01M | -240.23M | -204.15M |
| EBIT | -171.86M | -177.89M | -232.94M | -287.41M | -277.00M |
| EBITDA | 43.00M | 37.99M | -19.57M | -76.61M | -70.39M |
| EPS Basic | -5.56 | -1.17 | -0.96 | -1.32 | -1.14 |
| Normalized Basic EPS | -0.58 | -0.54 | -0.76 | -0.97 | -0.95 |
| EPS Diluted | -5.57 | -1.18 | -0.96 | -1.32 | -1.14 |
| Normalized Diluted EPS | -0.58 | -0.54 | -0.76 | -0.96 | -0.95 |
| Average Basic Shares Outstanding | 736.77M | 732.57M | 728.43M | 724.32M | 720.54M |
| Average Diluted Shares Outstanding | 736.77M | 732.57M | 731.85M | 727.74M | 723.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
